De novo CD5+ diffuse large B-cell lymphomas: A heterogeneous group containing an unusual form of splenic lymphoma

American Journal of Clinical Pathology

Volumn 114, Issue 4, 2000, Pages 523-533

  Kroft, Steven H ^a   Howard, Michael S ^a   Picker, Louis J ^a   Ansari, M Qasim ^a   Aquino, Deborah B ^a   McKenna, Robert W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD5; Cyclin D1; Large cell lymphoma; Mantle cell lymphoma; Splenic lymphoma

Indexed keywords

CD5 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MALE; MANTLE CELL LYMPHOMA; MORPHOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, NEOPLASM; CYCLIN D1; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; POINT MUTATION; SPLENIC NEOPLASMS;

EID: 0034425259     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/RM1Q-1T0B-WKQB-AF5A     Document Type: Article

References (36)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
2. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer. 1982;49:2112-2135.
3. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas [letter]. Lancet. 1988;1:292-293.
4. Harris N, Jaffe E, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000;13: 193-207.
5. Lozano F, Calvo J, Roca A, et al, eds. Leucocyte Typing VI. White Cell Differentiation Antigens. New York, NY: Garland Publishing; 1998.
6. Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol. 1995;147:207-216.
7. Kume M, Suzuki R, Yatabe Y, et al. Somatic hypermutation: in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas. Jpn J Cancer Res. 1997;88:1087-1093.
8. Taniguchi M, Oka K, Hiasa A, et al. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood. 1998;91:1145-1151.
9. Yatabe Y, Nakamura S, Seto M, et al. Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma: a distinct molecular pathologic entity. Am J Surg Pathol. 1996;20: 1110-1122.
10. Oka K, Ohno T, Kita K, et al. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Br J Haematol 1994;86:786-791.
11. Khalidi HS, Brynes RK, Browne P, et al. Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases. Mod Pathol. 1998;11:983-988.
12. Burns BF, Warnke RA, Doggett RS, et al. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas. Am J Pathol. 1983;113:165-171.
13. Zoldan MC, Inghirami G, Masuda Y, et al. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Haematol. 1996;93:475-486.
14. Miyamura K, Osada H, Yamauchi T, et al. Single clonal origin of neoplastic B-cells with different immunoglobulin light chains in a patient with Richter's syndrome. Cancer. 1990;66:140-144.
15. Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood. 1994;83:1363-1372.
16. Meeker TC, Shiramizu B, Kaplan L, et al. Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma. AIDS. 1991;5:669-674.
17. Itoyama T, Sadamori N, Tsutsumi K, et al. Primary central nervous system lymphomas: immunophenotypic, virologic, and cytogenetic findings of three patients without immune defects. Cancer. 1994;73:455-463.
18. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 1991;88:5413-5417.
19. Sander CA, Yano T, Clark HM, et al. p53 mutation is associated with progression in follicular lymphomas. Blood. 1993;82:1994-2004.
20. Lo Coco F, Gaidano G, Louie DC, et al. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood. 1993;82:2289-2295.
21. Yamaguchi M, Ohno T, Oka K, et al. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome. Br J Haematol. 1999;105:1133-1139.
22. Kraemer BB, Osborne BM, Butler JJ. Primary splenic presentation of malignant lymphoma and related disorders: a study of 49 cases. Cancer. 1984;54:1606-1619.
23. Arber DA, Rappaport H, Weiss LM. Non-Hodgkin's lymphoproliferative disorders involving the spleen. Mod Pathol. 1997;10:18-32.
24. Kaleem Z, Zehnbauer B, White G, et al. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphoma. Am J Clin Pathol. 2000;113:399-405.
25. Argatoff LH, Connors JM, Klasa RJ, et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89:2067-2078.
26. Pittaluga S, Verhoef G, Criel A, et al. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma: a study based on histology, cytology, immunohistochemistry, and cytogenetic analysis. Am J Surg Pathol. 1996;20:211-223.
27. Kroft S, Dawson D, Howard M, et al. Large cell transformation of chronic lymphocytic leukemia/small lymphocytic (CLL/SLL): a flow cytometric analysis of 7 cases [abstract]. Mod Pathol 2000;13:154A.
28. Arber DA, Jenkins KA. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996;106:462-468.
29. Palutke M, Eisenberg L, Narang S, et al. B lymphocytic lymphoma (large cell) of possible splenic marginal zone origin presenting with prominent splenomegaly and unusual cordai red pulp distribution. Cancer. 1988;62:593-600.
30. Salgado C, Feliu E, Montserrat E, et al. B-type large-cell primary splenic lymphoma with massive involvement of the red pulp. Acta Haematol. 1993;89:46-49.
31. Grossman D, Hanson C, Kueck B, et al. Red pulp splenic infiltration by B-cell immunoblastic lymphomas [abstract]. Mod Pathol. 1989;2:36A.
32. Harada S, Suzuki R, Uehira K, et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes. Leukemia. 1999;13:1441-1447.
33. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
34. DiGiuseppe JA, Borowitz MJ. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol. 1998;25:6-10.
35. Carbone A, Pinto A, Gloghini A, et al. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders. Hum Pathol. 1992;23:438-448.
36. Hernandez L, Fest T, Cazorla M, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood. 1996;87:3351-3359.